ALKS Company Profile and Key Details

Q: Who are the executives of ALKS?

Mr. Blair C. JacksonExecutive Vice President & Chief Operating OfficerMr. Thomas HarveyChief Information Officer & Senior Vice President of ITMs. Sandra CoombsSenior Vice President of Corporation Affairs & Investor RelationsMr. Richard F. PopsChairman & Chief Executive OfficerDr. Craig C. Hopkinson M.D.Executive Vice President of R&D and Chief Medical OfficerDr. Floyd E. Bloom M.D.FounderMr. Iain Michael BrownSenior Vice President & Chief Financial OfficerMr. Michael J. LandineSenior Vice President of Corporation Devel. & Chief Risk OfficerMr. Stephen SchiavoSenior Vice President of HRMr. David Joseph GaffinExecutive Vice President, Chief Legal Officer, Chief Compliance Officer & Sec.

NASDAQ : ALKS

Alkermes

$51.72

-1-1.90%

At Close 4:00 PM

51.6

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Alkermes plc (ALKS) stock surged +2.18%, trading at $52.85 on NASDAQ, up from the previous close of $51.72. The stock opened at $51.92, fluctuating between $51.25 and $53.04 in the recent session.

Stock Snapshot

51.72

Prev. Close

8.81B

Market Cap

51.2501

Day Low

55.63

P/E Ratio

0.95

EPS (TTM)

2.08

Cash Flow per Share

51.92

Open

166.68M

Number of Shares

53.04

Day High

98.53%

Free Float in %

7.07

Book Value

1.15M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 20, 2026	52.96	53.24	51.70	51.72	941.82K
Jul 17, 2026	51.06	52.79	50.94	52.72	1.71M
Jul 16, 2026	51.77	53.52	51.55	51.94	1.84M
Jul 15, 2026	51.64	52.20	50.49	51.98	1.56M
Jul 14, 2026	51.98	52.17	50.66	51.60	1.78M
Jul 13, 2026	51.07	52.00	50.54	51.87	1.58M
Jul 10, 2026	53.36	53.38	51.86	51.94	1.69M
Jul 09, 2026	54.46	54.90	53.36	53.78	1.63M
Jul 08, 2026	54.37	54.69	53.68	54.29	1.71M
Jul 07, 2026	55.37	55.67	53.63	55.22	1.72M
Jul 06, 2026	54.03	55.37	53.41	55.14	1.74M
Jul 02, 2026	52.50	54.69	51.72	54.58	1.65M
Jul 01, 2026	52.33	52.70	50.96	51.72	1.64M
Jun 30, 2026	52.78	53.35	51.85	52.40	2.94M
Jun 29, 2026	53.94	54.45	52.23	52.53	2.94M
Jun 26, 2026	52.87	55.28	52.39	55.08	7.48M
Jun 25, 2026	50.70	53.69	50.01	52.83	3.25M
Jun 24, 2026	48.94	51.73	48.88	50.45	3.73M
Jun 23, 2026	46.00	48.32	45.47	48.07	2.45M
Jun 22, 2026	45.40	46.63	45.01	46.02	3.23M

Contact Details

Dublin, DU D04 C5Y6

Ireland

http://www.alkermes.com 353 177 28000

About Company

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

Stock Peers

ARGX

-14.35998-1.67%

argenx SE$846.19 REGN

-4.53998-0.67%

Regeneron Pharmaceuticals, Inc.$672.15 MDGL

-17.78997-3.21%

Madrigal Pharmaceuticals, Inc.$535.69 UTHR

-6.33-1.18%

United Therapeutics Corporation$529.34 VRTX

-5.15-1.06%

Vertex Pharmaceuticals Incorporated$480.50 KRYS

-15.64-4.41%

Krystal Biotech, Inc.$339.22 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ONC

-1.445-0.46%

BeOne Medicines AG$310.58 PRAX

-9.98-3.17%

Praxis Precision Medicines, Inc.$304.43 LGND

-9.4-3.10%

Ligand Pharmaceuticals Incorporated$293.99

Frequently Asked Questions

What is the current Alkermes plc (ALKS) stock price?

Alkermes plc (NASDAQ: ALKS) stock price is $52.85 in the last trading session. During the trading session, ALKS stock reached the peak price of $53.04 while $51.25 was the lowest point it dropped to. The percentage change in ALKS stock occurred in the recent session was 2.18% while the dollar amount for the price change in ALKS stock was $1.13.

ALKS's industry and sector of operation?

The NASDAQ listed ALKS is part of Biotechnology industry that operates in the broader Healthcare sector. Alkermes plc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ALKS?

Mr. Blair C. Jackson
Executive Vice President & Chief Operating Officer
Mr. Thomas Harvey
Chief Information Officer & Senior Vice President of IT
Ms. Sandra Coombs
Senior Vice President of Corporation Affairs & Investor Relations
Mr. Richard F. Pops
Chairman & Chief Executive Officer
Dr. Craig C. Hopkinson M.D.
Executive Vice President of R&D and Chief Medical Officer
Dr. Floyd E. Bloom M.D.
Founder
Mr. Iain Michael Brown
Senior Vice President & Chief Financial Officer
Mr. Michael J. Landine
Senior Vice President of Corporation Devel. & Chief Risk Officer
Mr. Stephen Schiavo
Senior Vice President of HR
Mr. David Joseph Gaffin
Executive Vice President, Chief Legal Officer, Chief Compliance Officer & Sec.

How ALKS did perform over past 52-week?

ALKS's closing price is 105.48% higher than its 52-week low of $25.17 where as its distance from 52-week high of $55.67 is -7.09%.

How many employees does ALKS have?

Number of ALKS employees currently stands at 2,050.

Link for ALKS official website?

Official Website of ALKS is: http://www.alkermes.com

How do I contact ALKS?

ALKS could be contacted at phone 353 177 28000 and can also be accessed through its website. ALKS operates from Connaught House, Dublin, DU D04 C5Y6, Ireland.

How many shares of ALKS are traded daily?

ALKS stock volume for the day was 1.15M shares. The average number of ALKS shares traded daily for last 3 months was 2.23M.

What is the market cap of ALKS currently?

The market value of ALKS currently stands at $8.81B with its latest stock price at $52.85 and 166.68M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	2050
Beta	0.29
Sales or Revenue	$1.66B
5Y Sales Change%	0.418%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	2050
Beta	0.29
Sales or Revenue	$1.66B
5Y Sales Change%	0.418%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

ALKS Company Profile and Key Details

Alkermes

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Dividend & Fair Value

Company Overview

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Earnings & Analyst Outlook

Valuation Metrics

Key Takeaways

Price Forecast & Outlook